Factors predicting 10-year survival after heart transplantation

Branislav Radovancevic1, Cuneyt Konuralp, Bojan Vrtovec

  • 1Department of Cardiopulmonary Transplantation, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston, TX 77225, USA. bradovancevic@heart.thi.tmc.edu

Insights

Factors like pre-transplant diabetes, donor age, and early post-heart transplant (HTx) infections and rejections predict long-term survival. Managing these can improve outcomes for HTx patients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Identifying predictors of long-term survival is crucial for heart transplant (HTx) recipients.
  • Understanding factors influencing outcomes beyond 10 years post-transplant is essential for patient management.

Purpose of the Study:

  • To identify factors predictive of long-term (>10-year) survival in heart transplant recipients.
  • To compare characteristics and outcomes of long-term survivors with those with intermediate-term mortality.

Main Methods:

  • Retrospective analysis of 415 adult heart transplant recipients (August 1982 - May 1997).
  • Comparison of 158 patients surviving >10 years (Group A) with 116 patients who died between 2-6 years (Group B).
  • Evaluation of clinical, demographic, immunological, and post-transplant factors including infections, rejection, diabetes, and donor age.

Main Results:

  • Long-term survivors (Group A) had significantly fewer post-HTx rejection episodes and infections (bacterial, viral, fungal) compared to Group B.
  • Group A also exhibited lower mean donor age, reduced pre-HTx diabetes incidence, and lower cholesterol levels at 1 year post-HTx.
  • Multivariate analysis identified fewer bacterial infections, fewer rejection episodes, absence of pre-HTx diabetes, and lower donor age as significant predictors of longer survival.

Conclusions:

  • Pre-transplant diabetes, donor age, and early post-transplant infection and rejection incidences are key predictors of long-term (>10-year) survival.
  • Improved management and control of infections and rejection episodes within the first two years post-transplant may enhance long-term patient survival.
Abstract